Alzheon SAB Member Marwan Sabbagh, MD interview with NeurologyToday, an official publication of the American Academy of Neurology (AAN)

Is Targeting Oligomers in APOE4 Homozygotes the Path Forward in Alzheimer's Disease?

Article In Brief

Investigators review the scientific evidence for targeting amyloid oligomers and outline the case for a new drug in development for Alzheimer’s disease, ALZ-801, an orally administered prodrug of tramiprosate.

Read the full article here